Levonorgestrel
Key facts
| Active substance |
levonorgestrel
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/75/2010
|
| PIP number |
Levonorgestrel
|
| Pharmaceutical form(s) |
Intrauterine delivery system
|
| Condition(s) / indication(s) |
Contraception
|
| Route(s) of administration |
Intrauterine use
|
| Contact for public enquiries |
Bayer Schering Pharma AG
E-mail: pediatrics.medical-affairs-europe@bayerhealthcare.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|